Abiopharma

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

agilon health, inc. (AGL) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Lillys Taltz (ixekizumab) and Zepbound (tirzepatide) used together delivered superior efficacy in first-of-its-kind Phase 3b trial for adults with active psoriatic arthritis and obesity or overweight

📋 Kline Kyle (Officer) plans to sell 4K shares of GLOBUS MEDICAL INC (at $101.05 each, total $363K) Filed: Jan 08, 2026 | ID: 000005

ABOU RESIDENC-M (ABOU-M) was added to the list of traded instruments on TASE exchange

Indivior Notification

New Form SCHEDULE 13G/A - Arcus Biosciences, Inc. Filed: 2026-01-08 AccNo: 0002012383-26-000038 Size: 10 KB

New Form SCHEDULE 13G/A - PERRIGO Co plc Filed: 2026-01-08 AccNo: 0002012383-26-000036 Size: 10 KB

New Form SCHEDULE 13G/A - INDIVIOR PLC Filed: 2026-01-08 AccNo: 0002012383-26-000035 Size: 10 KB

Director Garth Tyler Hunter 🟢 acquired 200.0K shares of Bespoke Extracts, Inc. (BSPK) Transaction Date: Dec 30, 2025 | Filing ID: 002457

📋 Norwalk Leslie V (Director) plans to sell 2K shares of GLOBUS MEDICAL INC (at $101.00 each, total $202K) Filed: Jan 08, 2026 | ID: 000004

Securities Fraud Investigation Into agilon health, inc. (AGL) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

New Form SCHEDULE 13D/A - STAAR SURGICAL CO Filed: 2026-01-08 AccNo: 0000921895-26-000058 Size: 66 KB

New Form 1-A POS - Regen BioPharma Inc Filed: 2026-01-08 AccNo: 0001493152-26-000934 Size: 1 MB